Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jul;15(7):415-28.
doi: 10.1038/nri3855. Epub 2015 Jun 12.

Transcriptional regulation of innate lymphoid cell fate

Affiliations
Free article
Review

Transcriptional regulation of innate lymphoid cell fate

Nicolas Serafini et al. Nat Rev Immunol. 2015 Jul.
Free article

Abstract

Innate lymphoid cells (ILCs) are a recently described family of lymphoid effector cells that have important roles in immune defence, inflammation and tissue remodelling. It has been proposed that ILCs represent 'innate' homologues of differentiated effector T cells, and they have been categorized into three groups — namely, ILC1s, ILC2s and ILC3s — on the basis of their expression of cytokines and transcription factors that are typically associated with T helper 1 (T(H)1)-, T(H)2- and T(H)17-type immune responses, respectively. Indeed, remarkable similarity is seen between the specific transcription factors required for the development and diversification of different ILC groups and those that drive effector T cell differentiation. The recent identification of dedicated ILC precursors has provided a view of the mechanisms that control this first essential stage of ILC development. Here, we discuss the transcriptional mechanisms that regulate ILC development and diversification into distinct effector subsets with key roles in immunity and tissue homeostasis. We further caution against the current distinction between 'helper' versus 'killer' subsets in the evolving area of ILC nomenclature.

PubMed Disclaimer

References

    1. Nat Immunol. 2011 Dec 04;13(1):58-66 - PubMed
    1. J Immunol. 2005 Feb 1;174(3):1213-21 - PubMed
    1. J Exp Med. 2014 Aug 25;211(9):1733-40 - PubMed
    1. Immunity. 2008 Jun;28(6):751-62 - PubMed
    1. Immunity. 2013 Apr 18;38(4):769-81 - PubMed

Publication types